Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Capital Employed (2016 - 2025)

Amphastar Pharmaceuticals has reported Return on Capital Employed over the past 12 years, most recently at 0.02% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.02% for Q4 2025, down 13.0% from a year ago — trailing twelve months through Dec 2025 was 0.02% (down 13.0% YoY), and the annual figure for FY2025 was 0.02%, down 13.0%.
  • Return on Capital Employed for Q4 2025 was 0.02% at Amphastar Pharmaceuticals, down from 0.1% in the prior quarter.
  • Over the last five years, Return on Capital Employed for AMPH hit a ceiling of 0.18% in Q1 2023 and a floor of 0.02% in Q4 2025.
  • Median Return on Capital Employed over the past 5 years was 0.15% (2024), compared with a mean of 0.13%.
  • Biggest five-year swings in Return on Capital Employed: increased 11bps in 2022 and later dropped -13bps in 2025.
  • Amphastar Pharmaceuticals' Return on Capital Employed stood at 0.13% in 2021, then soared by 34bps to 0.17% in 2022, then decreased by -10bps to 0.15% in 2023, then dropped by -2bps to 0.15% in 2024, then crashed by -88bps to 0.02% in 2025.
  • The last three reported values for Return on Capital Employed were 0.02% (Q4 2025), 0.1% (Q3 2025), and 0.13% (Q2 2025) per Business Quant data.